Hypothalamic Hamartoma and Endocrinopathy: A Neurosurgeon's Perspective.

Autor: Doddamani RS; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India., Tripathi M; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India., Samala R; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India., Agrawal M; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India., Ramanujam B; Department of Neurology, All India Institute of Medical Sciences, New Delhi, India., Bajaj J; Department of Neurosurgery, Netaji Subhash Chandra Bose Medical College, Jabalpur, Madhya Pradesh, India., Girishan S; Department of Neurosurgery, MS Ramaiah Medical College and Hospital, Bengaluru, Karnataka, India., Tripathi M; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India., Bal CS; Department of Nuclear Medicine, All India Institute of Medical Sciences, New Delhi, India., Garg A; Department of Neuroradiology, All India Institute of Medical Sciences, New Delhi, India., Chandra PS; Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.
Jazyk: angličtina
Zdroj: Neurology India [Neurol India] 2020 May-Jun; Vol. 68 (Supplement), pp. S146-S153.
DOI: 10.4103/0028-3886.287681
Abstrakt: Background: The management of hypothalamic hamartomas (HH) rests upon the type of presentation. These are rare congenital benign lesions presenting either with central precocious puberty (CPP), drug refractory epilepsy (DRE) or combination of both. We present here our experience in the management of these lesions from a neurosurgeon's perspective and review the pertinent literature.
Objective: To present a series of HH presenting with CPP and DRE managed in the neurosurgery department at our center with an emphasis on the associated endocrine abnormalities.
Materials and Methods: A prospective observational study over a period of five years included 16 patients of HH. All patients were evaluated with 3 Tesla Magnetic Resonance Imaging (MRI) brain, complete hormonal workup including gonadotrophins, testosterone (males) and estradiol (females), and video-electroencephalography (VEEG) as a part of epilepsy workup. All these patients were evaluated with postoperative hormonal workup and repeat MRI brain if repeat surgery was contemplated.
Results: Among the 16 patients of HH, there were 11 male and 6 female children. All the patients presented with DRE with four of these had associated CPP. All the patients underwent robotic-guided radiofrequency ablation (RFA), with 75% seizure freedom following 1 st RFA surgery. Three of the four patients with CPP achieved both clinical and biochemical normalization. One patient had just a marginal reduction in the serum gonadotrophins. One patient was reoperated twice and three underwent RFA thrice.
Conclusion: The management of HH should be individualized with DRE taking the precedence requiring early surgery. A multidisciplinary approach is therefore recommended for a successful outcome.
Competing Interests: None
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje